Marksans Pharma reports 6% fall in Q4 consolidated net profit

30 May 2024 Evaluate

Marksans Pharma has reported results for fourth quarter (Q4) and year ended March 31, 2024.

The company has reported 85.23% rise in its net profit at Rs 32.99 crore for the quarter under review as compared to Rs 17.81 crore for the same quarter in the previous year. Total income of the company increased by 50.87% at Rs 237.39 crore for Q4FY24 as compared Rs 157.35 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 6.13% fall in its net profit at Rs  77.64 crore for fourth quarter ended March 31, 2024 as compared to Rs 82.71 crore for the same quarter in the previous year. However, total income of the company increased by 16.01% at Rs 576.54 crore for Q4FY24 as compared Rs 496.99 crore for the corresponding quarter previous year.

For the year ended March 31, 2024, the company has reported 30.03% rise in its net profit at Rs 133.76 crore as compared to Rs 102.87 crore for the previous year. Total income of the company increased by 27.90% at Rs 915.35 crore for year under review as compared to Rs 715.69 crore for year ended March 31, 2023.

For the year ended March 31, 2024, on the consolidated basis, the company has reported 18.69% rise in its net profit at Rs 314.90 crore as compared to Rs 265.32 crore for the previous year. Total income of the company increased by 16.55% at Rs 2227.83 crore for year under review as compared to Rs 1911.45 crore for year ended March 31, 2023.


Marksans Pharma Share Price

183.95 -3.95 (-2.10%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×